英国爱施得螯合铁价格(英国爱施得螯合铁价格分析及趋势预测)

Introduction

Iron deficiency anemia is a common condition worldwide, especially in developing countries. Iron is an essential mineral required for the production of hemoglobin, the protein in red blood cells responsible for carrying oxygen. Anemia occurs when the amount of hemoglobin in the blood is lower than normal, resulting in symptoms such as fatigue, weakness, and shortness of breath. One way to treat iron deficiency anemia is by the administration of iron supplements, such as iron chelates. In this article, we will analyze the price trend of one such iron chelate in the UK: ESIDREX?.

About ESIDREX?

ESIDREX? is a brand name for the iron chelate compound ferric hydroxide polymaltose complex. It is marketed by the French pharmaceutical company Sanofi and is used in the treatment of iron deficiency anemia. ESIDREX? is available as a solution for injection or as an oral suspension and has been approved for use in the UK since 1989.

Price Analysis

The price of ESIDREX? in the UK can fluctuate depending on several factors, including market demand, manufacturing costs, and availability of raw materials. In recent years, the price of ESIDREX? has remained relatively stable, with a slight upward trend. In 2018, the average wholesale price of one vial of ESIDREX? solution for injection (100mg/2mL) was ￡15.54. In 2019, the price increased slightly to ￡15.77 per vial. The price of the oral suspension (125mg/5mL) has also experienced a slight increase, from an average of ￡4.01 per bottle in 2018 to ￡4.18 per bottle in 2019.

Factors Impacting Price

There are several factors that can impact the price of ESIDREX? in the UK. One of the most significant is the availability of raw materials. ESIDREX? is made from a complex of iron and maltose, both of which can be costly to procure. If the cost of these raw materials increases, it can impact the overall cost of ESIDREX? and lead to an increase in price. Another factor that can impact the price of ESIDREX? is competition from other iron chelate products. If a new product enters the market, it can create price pressure on existing products like ESIDREX?. Finally, changes in the exchange rate between the pound and the euro can impact the price of ESIDREX? as Sanofi is a French company.

Price Comparisons

In comparison to other iron chelates available in the UK market, ESIDREX? is priced competitively. One of the most popular iron chelate products is Ferinject?, which is also marketed by Sanofi. In 2019, the average wholesale price of one vial of Ferinject? (50mg/2mL) was ￡27.88, almost double the price of ESIDREX?. Other iron chelates like Venofer? and Cosmofer? are also priced higher than ESIDREX?. However, it is worth noting that the dosage and administration of these products may differ from ESIDREX?, and patients should consult with their healthcare providers to determine the best treatment option for them.

Conclusion and Future Predictions

In conclusion, the price of ESIDREX? in the UK has remained stable overall, with a slight upward trend in recent years. Several factors can impact the price, including availability of raw materials and competition from other products. However, compared to other iron chelates available in the UK, ESIDREX? remains competitively priced. Looking to the future, it is difficult to predict how the price of ESIDREX? will change. However, as healthcare providers continue to recognize the importance of treating iron deficiency anemia, demand for iron chelate products like ESIDREX? is likely to remain strong.